Diabetes

Specific benefits patients with diabetes have experienced due to the ACA, and how those benefits are impacting diabetes costs.

Although the diabetes pipeline is not large, we continue to have progress in meeting the unmet needs of patients with diabetes.

Personalization is the key to a healthcare experience that optimizes outcomes, improves the customer experience and, ultimately, lowers costs to the healthcare system. Find out why it’s especially key for diabetic patients.

Mobile health (mHealth) offers new ways to empower patients with diabetes in caring for themselves and making decisions that support their health.

Telemedicine could improve diabetic patient outcomes, expand access, and provide better economic value for patients. Find out how.

Consequences range from cardiovascular disease to renal disease

Here are some of the innovative approaches payers and providers are taking to quell the diabetes epidemic, and curb the costs associated with it.

A successful YMCA diabetes program has prompted the Obama administration to expand Medicare to cover programs to prevent diabetes among those at high risk of developing the disease.

The sheer volume of diabetes patients has made it a big driver of medication spending. Here are some important formulary considerations.

… and solutions from experts

Rob Danoff, DO, of Aria Health System, explains what should be done to reduce health management costs, while improving care of diabetic patients.

In this Q&A, experts discuss how emerging treatments and technologies are affecting diabetes costs.

Humana is using past evidence to reach patients at risk for diabetes.

As 2016 gets underway, improvements in diabetes health management are expected to progress. Here are some of the noteworthy trends to watch.

While diabetes, particularly type 2, remains an epidemic, the number of new diagnoses has begun to slow. Here are some developments contributing to the decrease.

Broader exchange of ideas for diabetes health management and related programs may result in more efficient community-based programs with a wider impact.

Several studies have demonstrated that telemedicine programs of different types can yield the same or better results than more traditional diabetes interventions.

The results of a large study of the impact of empagliflozin (Jardiance) on cardiovascular outcomes were recently published. Here are some key takeaways.

An important question is whether improvements in technology can make better control accessible to patients who are not currently good candidates for insulin pumps.

For patients with diabetes or high blood cholesterol, greater medication adherence is associated with a greater likelihood that the patient will achieve target biometric A1c and low-density lipoprotein levels, respectively, according to a poster session presented at the Academy of Managed Care Pharmacy meeting.

During their session at the AMPC conference in Orlando, presenters identified several diabetes management approaches that are improving medication adherence.

Partner with community-based organizations to implement quality diabetes programs for the Hispanic population.

Further research may determine whether changing sedentary behavior will reduce long-term outcomes.

Canadian study shows certain ethnic groups face higher heart disease risk factors than they did a decade ago.

A medical group in New York is rapidly shifting toward “value-based” care from fee-for-service (FFS)-spurred on by a program to reduce variations in physician practice that began by focusing on patients with diabetes.